Naren Mallakunta has been named chief executive officer of Laxai Pharma, Ltd., joining the company’s management team. Mr. Mallakunta previously served as interim chief executive officer. Mr. Mallakunta has more than 23 years of management experience in marketing, project management, operations, finance and business development. Prior to joining Laxai, he served as the global head of business development at GVK Biosciences. “I am extremely excited about the prospects of Laxai. T...